Structure-activity relationship studies of PACAP-27 and VIP analogues.
作者信息
Kashimoto K, Nagano Y, Suitani Y, Hamanaka K, Mizumoto T, Tomizaki K, Takahata H, Nagamoto A, Ohata A, Yoshihara S, Ichimura T
机构信息
ItoHam Foods Inc., Central Research Institute, Ibaraki, Japan.
出版信息
Ann N Y Acad Sci. 1996 Dec 26;805:505-10. doi: 10.1111/j.1749-6632.1996.tb17511.x.
Abstract
摘要
相似文献
1
Structure-activity relationship studies of PACAP-27 and VIP analogues.促胰液素-27和血管活性肠肽类似物的构效关系研究
Ann N Y Acad Sci. 1996 Dec 26;805:505-10. doi: 10.1111/j.1749-6632.1996.tb17511.x.
2
Structure-activity studies on VIP: IV. The synthetic agonist helodermin-fragment-(1-28)-amide is a potent VIP-agonist with prolonged duration of tracheal relaxant activity.血管活性肠肽的构效关系研究：IV. 合成激动剂海洛德明片段-（1-28）-酰胺是一种强效血管活性肠肽激动剂，具有延长的气管舒张活性持续时间。
Ann N Y Acad Sci. 1996 Dec 26;805:499-504. doi: 10.1111/j.1749-6632.1996.tb17510.x.
3
A novel PACAP 1-27 analogue causes sustained smooth muscle relaxation in guinea-pig trachea.
Ann N Y Acad Sci. 1996 Dec 26;805:536-42. doi: 10.1111/j.1749-6632.1996.tb17515.x.
4
The effects of PACAP and VIP on guinea pig tracheal smooth muscle in vitro.垂体腺苷酸环化酶激活肽和血管活性肠肽对豚鼠气管平滑肌的体外作用。
Peptides. 1994;15(7):1237-41. doi: 10.1016/0196-9781(94)90147-3.
5
Effects of PACAP-VIP hybrid peptides on gastric blood flow in conscious dogs.垂体腺苷酸环化酶激活肽-血管活性肠肽杂合肽对清醒犬胃血流量的影响。
Ann N Y Acad Sci. 1996 Dec 26;805:511-5. doi: 10.1111/j.1749-6632.1996.tb17512.x.
6
Pituitary adenylate cyclase activating peptide mediates inhibitory nonadrenergic noncholinergic relaxation.
Eur J Pharmacol. 2000 Apr 21;395(1):77-83. doi: 10.1016/s0014-2999(00)00167-9.
7
Pituitary adenylate cyclase-activating peptide (PACAP), a VIP-like peptide, has prolonged airway smooth muscle relaxant activity.
Peptides. 1995;16(6):1057-61. doi: 10.1016/0196-9781(95)00087-z.
8
Role of Na(+)-K(+)-ATPase in airway smooth muscle relaxation by vasoactive intestinal peptide and pituitary adenylate cyclase activating peptide.钠钾ATP酶在血管活性肠肽和垂体腺苷酸环化酶激活肽介导的气道平滑肌舒张中的作用
Res Commun Chem Pathol Pharmacol. 1993 Jan;79(1):11-22.
9
Relaxant responses of VIP and PACAP in rat ileum: receptors and adaptive supersensitivity.
Ann N Y Acad Sci. 1998 Dec 11;865:393-6. doi: 10.1111/j.1749-6632.1998.tb11203.x.
10
Inhibitory effects of pituitary adenylate cyclase activating polypeptide on histamine-induced respiratory resistance in anesthetized guinea pigs.垂体腺苷酸环化酶激活多肽对组胺诱导的麻醉豚鼠呼吸阻力的抑制作用。
Regul Pept. 1997 May 14;70(1):9-13. doi: 10.1016/s0167-0115(97)00007-4.
引用本文的文献
1
Parasympathetic innervation of vertebrobasilar arteries: is this a potential clinical target?椎基底动脉的副交感神经支配：这是一个潜在的临床靶点吗？
J Physiol. 2016 Nov 15;594(22):6463-6485. doi: 10.1113/JP272450. Epub 2016 Oct 5.
2
Development of PACAP38 analogue with improved stability: physicochemical and in vitro/in vivo pharmacological characterization.开发稳定性提高的 PACAP38 类似物：理化性质和体外/体内药理学特性。
J Mol Neurosci. 2011 Jan;43(1):85-93. doi: 10.1007/s12031-010-9415-0. Epub 2010 Jun 29.
3
Structure-activity relationship of vasoactive intestinal peptide (VIP): potent agonists and potential clinical applications.血管活性肠肽（VIP）的构效关系：强效激动剂及潜在临床应用
Naunyn Schmiedebergs Arch Pharmacol. 2008 Jun;377(4-6):579-90. doi: 10.1007/s00210-007-0232-0. Epub 2008 Jan 3.
Zotero 插件